Search for: "EURAND, INC. et al v. Mylan Pharmaceuticals, Inc. et al"
Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
17 Nov 10:24 am by Barry Barnett
... : PLASMA-DERIVATIVE PROTEIN THERAPIES ANTITRUST LITIGATION Motion of plaintiff Hospital Damas, Inc., for centralization of the following actions in the United States District Court for the Northern District of Illinois: ... States District Court for the Southern District of Ohio: Northern District of Illinois Todd Wuerdeman v. Illinois Central Railroad Co., C.A. No. 1:08-6043 Southern ... . No. 8:09-1098 District of Delaware Eurand, Inc., et al. v. Mylan Pharmaceuticals, Inc., et al., C.A. No. 1:08-889 ...
Blawgletter - http://blawgletter.typepad.com/bbarnett/
1 Dec, 2008 3:33 am by Donald Zuhn
... filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.Eurand, Inc. et al. v. Mylan Pharmaceuticals, Inc. et al.1:08-cv-00210; filed November 26, 2008 in the Northern District of West VirginiaEurand, Inc. et al. v. Mylan Pharmaceuticals, Inc. et al.1:08-cv-00889; filed November 25, 2008 in the District Court of DelawareThe complaints in these cases are substantially identical. Infringement of U.S. Patent No. 7,387, ...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
6 Oct 12:41 am by The Docket Navigator
... to adjudicate time consuming and complex antitrust and patent misuse issues. . . . Further militating toward bifurcation of these issues if the dictinct lack of evidentiary overlap between issues of patent validity and infringement and issues of patent misuse and antitrust." Eurand Inc. et al. v. Mylan Pharmaceuticals Inc. et al., 1-08-cv-00889 (DED October 2, 2009, Memorandum Order) (Robinson, J.)
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
8 Oct 6:05 am
... ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? Have the inventor make a secret ... rules on Losartan paediatric extension: E I du Pont Nemours & Co v UK IPO (The SPC blog) Losartan- Latvia: Latvian Patent Office publishes ... Sometimes, sins of omission are not inequitable conduct: AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) Trileptal (Oxacarbazepine ...
IP Thinktank - http://duncanbucknell.com/blog
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck